Teva Pharmaceutical Industries Ltd. (TEVA)

8.04
0.10 1.26
NYSE : Health Technology
Prev Close 7.94
Open 7.85
Day Low/High 7.83 / 8.17
52 Wk Low/High 6.07 / 25.13
Volume 16.00M
Avg Volume 20.85M
Exchange NYSE
Shares Outstanding 1.09B
Market Cap 8.94B
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)
Takeda Pharmaceutical CEO Talks Big Pharma Trends

Takeda Pharmaceutical CEO Talks Big Pharma Trends

One of pharma's biggest CEO's talks M&A action on the exchange.

Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon

Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon

Do we have to run for the hills? Not necessarily.

Teva To Host Conference Call To Discuss Fourth Quarter And Full Year 2018 Financial Results At 8 A.m. ET On February 13, 2019

Teva To Host Conference Call To Discuss Fourth Quarter And Full Year 2018 Financial Results At 8 A.m. ET On February 13, 2019

Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced that it will issue a press release on its fourth quarter and full year 2018 financial results on Wednesday, February 13, 2019 at 7:00 a.

Teva To Present At The 37th Annual J.P. Morgan Healthcare Conference

Teva To Present At The 37th Annual J.P. Morgan Healthcare Conference

Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced that members of management will present at the 37th Annual J.

Teva And Amgen Resolve Ongoing Dispute Over Teva's Generic Cinacalet HCl Product

Teva And Amgen Resolve Ongoing Dispute Over Teva's Generic Cinacalet HCl Product

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced today that it has resolved its ongoing dispute with Amgen over Teva's generic cinacalcet HCl product.

Teva Announces FDA Approval Of First And Only Digital Inhaler With Built-In Sensors - ProAir® Digihaler™ (albuterol Sulfate 117 Mcg) Inhalation Powder

Teva Announces FDA Approval Of First And Only Digital Inhaler With Built-In Sensors - ProAir® Digihaler™ (albuterol Sulfate 117 Mcg) Inhalation Powder

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.

I See No Technical Reason to Approach Teva Pharmaceuticals From the Long Side

I See No Technical Reason to Approach Teva Pharmaceuticals From the Long Side

Jim Cramer was bearish on TEVA.

Teva, CyberArk, Ford: 'Mad Money' Lightning Round

Teva, CyberArk, Ford: 'Mad Money' Lightning Round

Jim Cramer weighs in on Teva, CyberArk and Ford.

Fighting the Fed: Cramer's 'Mad Money' Recap (Wednesday 12/19/18)

Fighting the Fed: Cramer's 'Mad Money' Recap (Wednesday 12/19/18)

Buying stocks now means you are in the uncomfortable position of fighting the Fed as it tries to slow the economy.

Teva Announces Positive Topline Phase IIIb Results With Fremanezumab In Adults With Migraine Who Did Not Respond To Multiple Classes Of Preventive Treatments

Teva Announces Positive Topline Phase IIIb Results With Fremanezumab In Adults With Migraine Who Did Not Respond To Multiple Classes Of Preventive Treatments

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced positive topline results from the Phase IIIb FOCUS study that evaluated the efficacy and safety of fremanezumab for the preventive treatment of migraine in adult patients who...

Teva's Generic Version Of EpiPen® (Epinephrine Injection, USP) Auto-Injector 0.3 Mg Now Available In Limited Quantity In The United States

Teva's Generic Version Of EpiPen® (Epinephrine Injection, USP) Auto-Injector 0.3 Mg Now Available In Limited Quantity In The United States

Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced the release of limited doses of the FDA-approved generic version of EpiPen ®1 (epinephrine injection, USP) Auto-Injector, 0.

Mylan May Make Generics but Its Charts are Starting to Look 'Name Brand'

Mylan May Make Generics but Its Charts are Starting to Look 'Name Brand'

Let's check of the charts and indicators to see if this is a good time to approach the long side of MYL.

Fab Five FAANG Stocks: Cramer's 'Mad Money' Recap (Tuesday 11/13/18)

Fab Five FAANG Stocks: Cramer's 'Mad Money' Recap (Tuesday 11/13/18)

Jim Cramer's got a different perspective on the recent performance of the companies we love to hate: Facebook, Amazon, Apple, Netflix, Google.

Dropbox, Teva Pharmaceuticals, Salesforce: 'Mad Money' Lightning Round

Dropbox, Teva Pharmaceuticals, Salesforce: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Dropbox, Teva Pharmaceuticals, Salesforce, Linde, iQiyi and more.

Eli Lilly Shares Decline on Tuesday Despite Strong Earnings Release

Eli Lilly Shares Decline on Tuesday Despite Strong Earnings Release

Eli Lilly's excellent earnings weren't excellent enough.

Eli Lilly Offers Healthy Outlook to Kick Off November

Eli Lilly Offers Healthy Outlook to Kick Off November

The giant drugmaker raised its profit guidance for all of 2018 after its third-quarter results beat expectations.

Teva Soars After Earnings Beat, Increased Guidance

Teva Soars After Earnings Beat, Increased Guidance

The Israel-based drugmaker also said it is on pace to meet its cost reduction goal aimed at lowering its total cost base by $3 billion by the end of 2019.

Markets Are Headed For a More Difficult Environment: Market Recon

Markets Are Headed For a More Difficult Environment: Market Recon

Santa is on his way... A lot of pressure on the jolly fellow this year.

Teva Reports Third Quarter 2018 Financial Results

Teva Reports Third Quarter 2018 Financial Results

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended September 30, 2018.

Teva And New Jersey Governor Murphy Formalize North America Headquarters Move With Ceremony In Israel

Teva And New Jersey Governor Murphy Formalize North America Headquarters Move With Ceremony In Israel

Teva Pharmaceuticals announced that Teva executives Kåre Schultz and Brendan O'Grady, alongside State of New Jersey Governor, Phil Murphy, formalized Teva's commitment to consolidate its North America Commercial business areas into New Jersey (NJ) today...

Teva Presents 25-year Safety Data From Longest Continuous Trial Of COPAXONE® (glatiramer Acetate Injection) For The Treatment Of Relapsing Forms Of Multiple Sclerosis

Teva Presents 25-year Safety Data From Longest Continuous Trial Of COPAXONE® (glatiramer Acetate Injection) For The Treatment Of Relapsing Forms Of Multiple Sclerosis

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced safety and tolerability results representing 25 years of data from the open-label extension study of the original U.

Teva To Present New Data At 34th European Committee For Treatment And Research In Multiple Sclerosis Congress In Berlin

Teva To Present New Data At 34th European Committee For Treatment And Research In Multiple Sclerosis Congress In Berlin

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that new data on COPAXONE ® (glatiramer acetate injection), a product for relapsing forms of multiple sclerosis (RMS), will be presented at the 34 th Congress of the European...

Teva To Report Third Quarter 2018 Financial Results On November 1, 2018

Teva To Report Third Quarter 2018 Financial Results On November 1, 2018

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will release its third quarter 2018 financial results on Thursday, November 1, 2018 at 7:00 a.

Teva Announces Exclusive First-to-File Launch Of A Generic Version Of Cialis® In The United States

Teva Announces Exclusive First-to-File Launch Of A Generic Version Of Cialis® In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the exclusive first-to-file launch of a generic version of Cialis ®1 (tadalafil) tablets (2.

Amarin's Huge Rally: Here's Why the Stock Is Soaring and How to Trade It

Amarin's Huge Rally: Here's Why the Stock Is Soaring and How to Trade It

For equity holders in Amarin, now's the time to be implementing my 'Jensen Rules.'

Teva Announces Early Results Of Debt Tender Offer And Election Of Early Settlement

Teva Announces Early Results Of Debt Tender Offer And Election Of Early Settlement

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the early tender results in connection with its previously announced tender offers (the " Offers ") to purchase for cash for a combined aggregate purchase price (exclusive of accrued and...

Stocks End Near Day's Lows on Expectations of New China Tariffs

Stocks End Near Day's Lows on Expectations of New China Tariffs

Stocks ended near their lows of the day as President Trump teased a trade announcement after the bell.

TheStreet Quant Rating: D (Sell)